Long-term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma

We report the long-term follow-up results of a phase II trial of thalidomide for early stage multiple myeloma (MM). Patients were eligible if they had smoldering multiple myeloma (SMM) or indolent MM without need for immediate therapy. Thalidomide was initiated at a dose of 200 mg/day and adjusted a...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Detweiler-Short, Kristen, Hayman, Suzanne, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Kumar, Shaji, Zeldenrust, Steven R., Russell, Stephen J., Lust, John A., Kyle, Robert A., Greipp, Philip R., Witzig, Thomas E., Rajkumar, S. Vincent
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2010
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3022372/
https://ncbi.nlm.nih.gov/pubmed/20730790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.21821
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन